Hanmi Science Co., Ltd. (KRX:008930)
47,250
+550 (1.18%)
Last updated: Feb 26, 2026, 10:58 AM KST
Hanmi Science Market Cap
Hanmi Science has a market cap or net worth of 3.16 trillion as of February 25, 2026. Its market cap has increased by 68.59% in one year.
Market Cap
3.16T
Enterprise Value
3.29T
Revenue
1.34T
Ranking
n/a
PE Ratio
42.07
Stock Price
47,250.00
Market Cap Chart
Since August 28, 1995, Hanmi Science's market cap has increased from 36.00B to 3.16T, an increase of 8,683.99%. That is a compound annual growth rate of 15.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 3.17T | 28.97% |
| Dec 30, 2025 | 2.45T | 23.09% |
| Dec 30, 2024 | 1.99T | -25.17% |
| Dec 28, 2023 | 2.66T | 20.78% |
| Dec 29, 2022 | 2.21T | -39.49% |
| Dec 30, 2021 | 3.65T | -27.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 80.36T |
| Celltrion | 52.97T |
| ALTEOGEN | 21.50T |
| Sam Chun Dang Pharm. | 14.95T |
| Celltrion Pharm | 3.34T |
| ST Pharm | 3.12T |
| L&C BIO Co.,LTD | 2.94T |
| Hanall Biopharma | 2.80T |